In the TME of the TC-1 tumor, the T cell compartment, consisting of CD8+ and CD4+ Tconvs and FOXP3+ Tregs, comprised only 11.1% of the CD45+ hematopoietic cell infiltrate, as identified by flow cytometry. The gene discussed is CD8A; the disease is neoplasm.